Granulox is only to be used by health care professionals or lay persons under supervision of health care professionals and is suitable for repeated use.
Granulox is an innovative medical device for the treatment of chronic wounds, such as venous leg ulcers, arterial leg ulcers, mixed leg ulcers, diabetic foot ulcers, surgical wounds healing by secondary intention and pressure injuries. Granulox can also be used on sloughy and infected wounds as an adjunct to standard of care. Granulox provides the wound with oxygen by means of diffusion. The haemoglobin supplies the base of the wound with oxygen. The improved oxygen supply to the base of the wound supports wound healing.
Benefits:
- Time to heal diabetic foot ulcer is 50% shorter with Granulox than with standard of care
- Twice as many chronic wounds healed using Granulox at 8–16 weeks compared to standard of care
- More than 70% lower average pain scores at four weeks using Granulox than with standard of care in chronic wounds
- Less slough during wound management: 99% less slough in chronic wounds after four weeks using Granulox compared to 33% with standard of care
- Using Granulox as an adjunct therapy, approximately 90% more wounds healed compared to standard of care alone